Grossman Adam S
CIK 0001542517
President,CEO, and Interim CFODirector
Filings
41
Latest Mar 17, 2026
Issuers covered
1
Showing
41 of 41
Page 1
Track record
31 of 31 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 31 | 71% | +3.2% | +5.8% | +32.8% | -26.0% |
| 90 days | 29 | 69% | +5.8% | +10.4% | +47.5% | -66.0% |
| 180 days | 25 | 76% | +7.2% | +5.0% | +47.5% | -84.7% |
| 365 days | 13 | 69% | -56.3% | +13.5% | +56.9% | -344.4% |
Issuers
Companies where Grossman Adam S has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| ADMA | Adma Biologics, Inc. | 41 | Mar 17, 2026 |
All filings
41 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|